Related Experiment Video
Updated: Mar 19, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Nutritional and Metabolic Characteristics of Overweight Women with Polycystic Ovary Syndrome (PCOS): A Case-Control
Kamilia Ounaissa1, Sana Khamassi1, Taieb Ach2
1Zouhair Kallel Institute of Nutrition and Food Technology, Department of Nutritional Diseases D, 1007, Tunis, Tunisia.
Introduction:
Polycystic Ovary Syndrome (PCOS) is a common cause of menstrual disorders, infertility, and hyperandrogenism, often associated with insulin resistance and an increased risk of metabolic disorders. This study aimed to assess the metabolic and nutritional characteristics of overweight women with PCOS.
Methods:
This was a descriptive, cross-sectional, and retrospective case-control study that included 61 overweight women, divided into two groups: 31 women with PCOS and 30 controls without PCOS. Data were gathered through review of the patients' medical records.
Results:
High blood pressure, type 2 diabetes, dyslipidemia, and metabolic syndrome were significantly more frequent in the PCOS group compared to the control group (p<0.001; p<0.001; p=0.002; and p=<00001, respectively). Eating disorders were more frequently observed in women with PCOS, with a significantly higher occurrence of binge eating behaviors in these patients compared to the control group (p=0.009). The intake of saturated fatty acids was higher in women with PCOS (p=0.01). Regarding micronutrients, intakes of vitamin C and vitamin B1 were significantly lower in PCOS patients (p=0.01 and p=0.04, respectively). However, significantly more prevalent nutrient deficiencies in omega-6 fatty acids (p=0.001), vitamin C (p=0.002), vitamin B1 (p=0.03), vitamin B3 (p=0.003), vitamin B6 (p=0.03), and iron (p=0.02) were noted in the PCOS group.
Conclusions:
Women with PCOS exhibit a higher occurrence of cardio-metabolic risk factors and multiple nutritional deficiencies. Early and personalized management is crucial to improve their long-term health outcomes and quality of life.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Oogenesis
Drug Dosing: Obese Patients
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

